Response to Therapy
On average, >30% of all patients treated with sacubitril/valsartan were defined as responders at week 8 (ie, achieving BP control with 24‐hour SBP <130 mm Hg and 24‐hour DBP <80 mm Hg). In addition, BP control rates at week 8 were higher in both sacubitril/valsartan groups than with olmesartan in the nondipper subgroup, whereas differences between sacubitril/valsartan and olmesartan were less marked in the dipper subgroup (Figure 